MaineMOM initiative aims to improve care for pregnant and postpartum women with Opioid Use Disorder (OUD) and their infants by integrating maternal and substance use treatment services.
See the MaineMOM FactSheet (PDF) for a summary of the model.
MaineMOM Goals
MaineMOM model includes:
- Welcoming and engaging women in care
- Supporting the treatment and recovery of mothers with group-based medication-assisted treatment
- Increasing the capacity of integrated care teams to deliver evidence-based care, including through telehealth
- Coordinating delivery, hospital, and post-partum care for mothers and infants
- Enhancing home visiting and community supports
- Conducting a public outreach campaign
Grant Award
Maine was awarded $5.3 million in federal grant funds from the Centers for Medicare and Medicaid (CMS) to participate in the Maternal Opioid Misuse (MOM) model. See the CMS MOM Press Release or the Maine DHHS MOM Award Press Release for more information about the award.
Maine Partners
The Office of MaineCare Services will collaborate with six care delivery partners statewide to deliver MaineMOM Services by July 1, 2021:
- MaineGeneral Medical Center
- MaineHealth
- Mid Coast-Parkview Hospital
- Northern Light Health
- Penobscot Community Health Care
- Pines Health Services
Why is MaineMOM significant?
In state fiscal year 2018, the DHHS Office of Child and Family Services received 904 reports regarding infants born exposed to substances, including opioids, which was approximately seven percent of live births in Maine. This includes babies born to mothers who are on recommended medication-assisted treatment. Infants exposed to opioids before birth are at a higher risk of being born early and with lower birth weights.